Home/Court of Appeals of Texas/Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P.

Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P.

CourtCourt of Appeals of Texas
DecidedDecember 28, 2023
Docket14-22-00882-CV
StatusPublished

This text of Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P. (Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P.) is published on Counsel Stack Legal Research, covering Court of Appeals of Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P., (Tex. Ct. App. 2023).

Opinion

Motion Granted; Appeal Dismissed and Memorandum Opinion filed December 28, 2023

In The

Fourteenth Court of Appeals

NO. 14-22-00882-CV

NAVIDEA BIOPHARMACEUTICALS, INC. AND MACROPHAGE THERAPEUTICS, INC., Appellants

V.

CAPITAL ROYALTY PARTNERS II, L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND “A”, L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS, II, L.P.; CAPITAL ROYALTY PARTNERS II (CAYMAN) L.P.; CR GROUP, L.P.; CRG SERVICING, LLC; AND CAPITAL ROYALTY PARTNERS II – PARALLEL FUND “B” (CAYMAN) L.P., Appellees

On Appeal from the 151st District Court Harris County, Texas Trial Court Cause No. 2018-24442

MEMORANDUM OPINION This is an appeal from a judgment signed September 1, 2022. On December 6, 2023, appellants filed an agreed motion to dismiss the appeal. See Tex. R. App. P. 42.1. The motion is granted. Costs are taxed against the party incurring such costs.

We dismiss the appeal.

PER CURIAM

Panel consists of Justices Bourliot, Zimmerer and Spain.

Free access — add to your briefcase to read the full text and ask questions with AI

Cite This Page — Counsel Stack

Bluebook (online)
Navidea Biopharmaceuticals, Inc. and MacRophage Therapeutics, Inc. v. Capital Royalty Partners II, L.P., Capital Royalty Partners II - Parallel Fund "A", L.P., Parallel Investment Opportunities Partners, II, L.P., Capital Royalty Partners II (Cayman) L.P., CR Group, L.P., CRG Servicing, LLC, and Capital Royalty Partners II – Parallel Fund "B" (Cayman) L.P., Counsel Stack Legal Research, https://law.counselstack.com/opinion/navidea-biopharmaceuticals-inc-and-macrophage-therapeutics-inc-v-texapp-2023.